Decreased Pattern Recognition Receptor Signaling, Interferon-Signature, and Bactericidal/Permeability-Increasing Protein Gene Expression in Cord Blood of Term Low Birth Weight Human Newborns

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Singh, Vikas Vikram ^a   Chauhan, Sudhir Kumar ^a   Rai, Richa ^a   Kumar, Ashok ^b   Singh, Shiva M ^c   Rai, Geeta ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; INTERFERON REGULATORY FACTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 8; ANTIMICROBIAL CATIONIC PEPTIDE; INITIATION FACTOR 2; INTERFERON; PLASMA PROTEIN;

ARTICLE; CLINICAL ARTICLE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; INFECTION RISK; LOW BIRTH WEIGHT; MICROARRAY ANALYSIS; NEWBORN; NUCLEOTIDE SEQUENCE; PERMEABILITY; SIGNAL TRANSDUCTION; TLR 1 GENE; TLR 5 GENE; TLR 8 GENE; UMBILICAL CORD BLOOD; ADULT; CLUSTER ANALYSIS; COMMUNICABLE DISEASE; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; VIROLOGY;

BACTERIA (MICROORGANISMS);

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CLUSTER ANALYSIS; COMMUNICABLE DISEASES; EUKARYOTIC INITIATION FACTOR-2; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERFERONS; RECEPTORS, PATTERN RECOGNITION; REPRODUCIBILITY OF RESULTS; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 8;

EID: 84876561754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062845     Document Type: Article

References (81)

1. Acheson ED, (1965) Hospital morbidity in early life in relation to certain maternal and foetal characteristics and events at delivery. Br J Prev Soc Med 19: 164-173.
2. Ashworth A, (1998) Effects of intrauterine growth retardation on mortality and morbidity in infants and young children. Eur J Clin Nutr 52Suppl 1: S34-42.
3. Valero De Bernabe J, Soriano T, Albaladejo R, Juarranz M, Calle ME, et al. (2004) Risk factors for low birth weight: a review. Eur J Obstet Gynecol Reprod Biol 116: 3-15.
4. United Nation Children's Fund, World Health Organization (2004) Low Birthweight: Country, regional and global estimates. UNICEF, New York. Available: http://www.unicef.org/publications/index_24840.html. Accessed 6th January 2008.
5. de Onis M, Blossner M, Villar J, (1998) Levels and patterns of intrauterine growth retardation in developing countries. Eur J Clin Nutr 52Suppl 1: S5-15.
6. National Neonatology Forum of India, World Health Organization (South East Asia Region Organization), United Nations Children's Fund India, World Bank, Saving Newborn Lives, Save the Children/US (2004) The State of the India's newborns. New Delhi/Washington, DC. Avaliable: http://www.healthynewbornnetwork.org/resource/state-indias-newborns. Accessed 7thJanuary 2008.
7. Lira PI, Ashworth A, Morris SS, (1996) Low birth weight and morbidity from diarrhea and respiratory infection in northeast Brazil. J Pediatr 128: 497-504.
8. Fonseca W, Kirkwood BR, Victora CG, Fuchs SR, Flores JA, et al. (1996) Risk factors for childhood pneumonia among the urban poor in Fortaleza, Brazil: a case-control study. Bull World Health Organ 74: 199-208.
9. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, et al. (2004) Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173: 4627-4634.
10. Marodi L, (2006) Innate cellular immune responses in newborns. Clin Immunol 118: 137-144.
11. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, et al. (2007) Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 195: 296-302.
12. Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, et al. (2009) Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 183: 7150-7160.
13. Chandra RK, (1975) Fetal malnutrition and postnatal immunocompetence. Am J Dis Child 129: 450-454.
14. Singh M, Manerikar S, Malaviya AN, Premawathi, Gopalan R, et al. (1978) Immune status of low birth weight babies. Indian Pediatr 15: 563-567.
15. Saha K, Kaur P, Srivastava G, Chaudhury DS, (1983) A six-months' follow-up study of growth, morbidity and functional immunity in low birth weight neonates with special reference to intrauterine growth retardation in small-for-gestational-age infants. J Trop Pediatr 29: 278-282.
16. Ferguson AC, (1978) Prolonged impairment of cellular immunity in children with intrauterine growth retardation. J Pediatr 93: 52-56.
17. Chatrath R, Saili A, Jain M, Dutta AK, (1997) Immune status of full-term small-for-gestational age neonates in India. J Trop Pediatr 43: 345-348.
18. Samarajiwa SA, Forster S, Auchettl K, Hertzog PJ, (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37: D852-857.
19. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
20. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
21. Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, et al. (1999) Protective effects of C5a blockade in sepsis. Nat Med 5: 788-792.
22. Christophe T, Rabiet MJ, Tardif M, Milcent MD, Boulay F, (2000) Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells. J Biol Chem 275: 1656-1664.
23. Nybo M, Sorensen O, Leslie R, Wang P, (1998) Reduced expression of C5a receptors on neutrophils from cord blood. Arch Dis Child Fetal Neonatal Ed 78: F129-132.
24. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
25. Cervantes JL, Weinerman B, Basole C, Salazar JC, (2012) TLR8: the forgotten relative revindicated. Cell Mol Immunol 9: 434-438.
26. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, et al. (2004) Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 72: 1223-1229.
27. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, et al. (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 8: 878-884.
28. Munoz N, Van Maele L, Marques JM, Rial A, Sirard JC, et al. (2010) Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect Immun 78: 4226-4233.
29. Philbin VJ, Dowling DJ, Gallington LC, Cortes G, Tan Z, et al. (2012) Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. J Allergy Clin Immunol 130: 195-204 e199.
30. Dowling DJ, Tan Z, Prokopowicz ZM, Palmer CD, Matthews MA, et al. (2013) The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes. PLoS One 8: e58164.
31. Bendelja K, Vojvoda V, Aberle N, Cepin-Bogovic J, Gagro A, et al. (2010) Decreased Toll-like receptor 8 expression and lower TNF-alpha synthesis in infants with acute RSV infection. Respir Res 11: 143.
32. Eckert M, Wittmann I, Rollinghoff M, Gessner A, Schnare M, (2006) Endotoxin-induced expression of murine bactericidal permeability/increasing protein is mediated exclusively by toll/IL-1 receptor domain-containing adaptor inducing IFN-beta-dependent pathways. J Immunol 176: 522-528.
33. Kollmann TR, Levy O, Montgomery RR, Goriely S, (2012) Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37: 771-783.
34. Babu S, Blauvelt CP, Kumaraswami V, Nutman TB, (2005) Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol 175: 1170-1176.
35. Alvarez JI, (2005) Inhibition of Toll Like Receptor immune responses by microbial pathogens. Front Biosci 10: 582-587.
36. Honda K, Takaoka A, Taniguchi T, (2006) Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
37. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin Immunol 20: 17-22.
38. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
39. Terenzi F, Hui DJ, Merrick WC, Sen GC, (2006) Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem 281: 34064-34071.
40. Skaug B, Chen ZJ, (2010) Emerging role of ISG15 in antiviral immunity. Cell 143: 187-190.
41. Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL, (2004) Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 169: 70-76.
42. De Wit D, Olislagers V, Goriely S, Vermeulen F, Wagner H, et al. (2004) Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 103: 1030-1032.
43. Danis B, George TC, Goriely S, Dutta B, Renneson J, et al. (2008) Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur J Immunol 38: 507-517.
44. Holcik M, Sonenberg N, (2005) Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6: 318-327.
45. Williams BR, (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18: 6112-6120.
46. Williams BR, (2001) Signal integration via PKR. Sci STKE 2001: re2.
47. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70: 1032-1060.
48. Kaufman RJ, (1999) Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc Natl Acad Sci U S A 96: 11693-11695.
49. Scheuner D, Patel R, Wang F, Lee K, Kumar K, et al. (2006) Double-stranded RNA-dependent protein kinase phosphorylation of the alpha-subunit of eukaryotic translation initiation factor 2 mediates apoptosis. J Biol Chem 281: 21458-21468.
50. de Veer MJ, Holko M, Frevel M, Walker E, Der S, et al. (2001) Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69: 912-920.
51. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
52. Terenzi F, White C, Pal S, Williams BR, Sen GC, (2007) Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J Virol 81: 8656-8665.
53. Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, et al. (2011) IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat Immunol 12: 624-630.
54. Li Y, Li C, Xue P, Zhong B, Mao AP, et al. (2009) ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc Natl Acad Sci U S A 106: 7945-7950.
55. Berchtold S, Manncke B, Klenk J, Geisel J, Autenrieth IB, et al. (2008) Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels. BMC Immunol 9: 75.
56. Sakata H, Yoshioka H, Fujita K, (1985) Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr 144: 186-190.
57. Tazawa Y, Yamada M, Ito K, Nakae S, Hayamizu S, et al. (1989) Cytomegalovirus infection in low-birth-weight infants with acute respiratory tract disease. Tohoku J Exp Med 158: 221-226.
58. Kalanda B, Verhoeff F, le Cessie S, Brabin J, (2009) Low birth weight and fetal anaemia as risk factors for infant morbidity in rural Malawi. Malawi Med J 21: 69-74.
59. Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, et al. (2002) Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 346: 149-157.
60. Syddall HE, Sayer AA, Simmonds SJ, Osmond C, Cox V, et al. (2005) Birth weight, infant weight gain, and cause-specific mortality: the Hertfordshire Cohort Study. Am J Epidemiol 161: 1074-1080.
61. Walter EC, Ehlenbach WJ, Hotchkin DL, Chien JW, Koepsell TD, (2009) Low birth weight and respiratory disease in adulthood: a population-based case-control study. Am J Respir Crit Care Med 180: 176-180.
62. Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, et al. (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 6: 2.
63. Scagnolari C, Midulla F, Pierangeli A, Moretti C, Bonci E, et al. (2009) Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin Vaccine Immunol 16: 816-823.
64. Takeuchi O, Akira S, (2008) MDA5/RIG-I and virus recognition. Curr Opin immunol 20: 17-22.
65. Tregoning JS, Schwarze J, (2010) Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clinical microbiology reviews 23: 74-98.
66. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
67. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M Jr, (2008) Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 82: 609-616.
68. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, et al. (2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-345.
69. Rot A, von Andrian UH, (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22: 891-928.
70. Zlotnik A, Yoshie O, (2000) Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
71. Sabroe I, Jones EC, Whyte MK, Dower SK, (2005) Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4. Immunology 115: 90-98.
72. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
73. Ewen CL, Kane KP, Bleackley RC, (2012) A quarter century of granzymes. Cell Death Differ 19: 28-35.
74. Wang Y, Xu H, Zheng X, Wei H, Sun R, et al. (2007) High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol 4: 377-382.
75. Weiss J, Elsbach P, Olsson I, Odeberg H, (1978) Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 253: 2664-2672.
76. Calafat J, Janssen H, Tool A, Dentener MA, Knol EF, et al. (1998) The bactericidal/permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood 91: 4770-4775.
77. Mannion BA, Weiss J, Elsbach P, (1990) Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest 86: 631-641.
78. Levy O, (2000) A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein. Antimicrob Agents Chemother 44: 2925-2931.
79. Levy O, (2002) Therapeutic potential of the bactericidal/permeability-increasing protein. Expert Opin Investig Drugs 11: 159-167.
80. Palmer CD, Guinan EC, Levy O, (2011) Deficient expression of bactericidal/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy. Biochem Soc Trans 39: 994-999.
81. Levy O, Martin S, Eichenwald E, Ganz T, Valore E, et al. (1999) Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 104: 1327-1333.